Literature DB >> 27798862

Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies.

Stergios Boussios1, George Zarkavelis2, Esmeralda Seraj2, Ioannis Zerdes2, Konstantina Tatsi3, George Pentheroudakis2.   

Abstract

Non-epithelial ovarian cancers (NEOC) are a group of fascinating but uncommon malignancies which can be extremely challenging to treat. Collectively, these tumours only represent 10-15% of all ovarian cancers and occur in all age groups from childhood to old age. This broad term includes diverse tumours of germ cell origin, sex cord-stromal cell origin, as well as extremely rare types of ovarian cancer, such as small-cell carcinomas and sarcomas, each of which require specialist management. It is imperative that these rare tumours are managed with accurate diagnosis, staging and treatment in order to optimize patient outcomes. The aetiology and molecular origins of each sub-group of NEOC remain poorly understood and international cooperation to facilitate high quality translational research is needed. This review summarizes the published literature on the incidence, clinical presentation, pathology, therapeutic interventions, survival and prognostic factors of each sub-type of NEOC. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Germ cell tumours; review; sex cord-stromal tumours

Mesh:

Year:  2016        PMID: 27798862     DOI: 10.21873/anticanres.11072

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  22 in total

Review 1.  Oncological Prognosis and Fertility Outcomes of Different Surgical Extents for Malignant Ovarian Sex-Cord Stromal Tumors: A Narrative Review.

Authors:  Jiawei Li; Jun Li; Wei Jiang
Journal:  Cancer Manag Res       Date:  2022-02-18       Impact factor: 3.989

2.  Genetic Analysis and Combined Therapy of Surgery and Chemotherapy for the Progression-Free Survival of a Patient with Ovarian Carcinosarcoma: A Case Report and Literature Review.

Authors:  Shanshan Guo; Xiaoyun Zhang; Qianjue Tang; Mengyun Zhou; Dan Jiang; Erkai Yu
Journal:  Onco Targets Ther       Date:  2022-06-29       Impact factor: 4.345

Review 3.  Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes.

Authors:  Sidrah Shah; Alison Cheung; Mikolaj Kutka; Matin Sheriff; Stergios Boussios
Journal:  Int J Environ Res Public Health       Date:  2022-07-01       Impact factor: 4.614

4.  Insight updating of the molecular hallmarks in ovarian carcinoma.

Authors:  Alba Mota; Sara S Oltra; Gema Moreno-Bueno
Journal:  EJC Suppl       Date:  2020-08-22

5.  Hsa_circ_0001756 promotes ovarian cancer progression through regulating IGF2BP2-mediated RAB5A expression and the EGFR/MAPK signaling pathway.

Authors:  Jing Ji; Chen Li; Jinfeng Wang; Lei Wang; Huifang Huang; Ying Li; Jing Fang
Journal:  Cell Cycle       Date:  2022-02-03       Impact factor: 5.173

6.  A Resident's Perspective of Ovarian Cancer.

Authors:  Christopher G Smith
Journal:  Diagnostics (Basel)       Date:  2017-04-27

Review 7.  Cell Origins of High-Grade Serous Ovarian Cancer.

Authors:  Jaeyeon Kim; Eun Young Park; Olga Kim; Jeanne M Schilder; Donna M Coffey; Chi-Heum Cho; Robert C Bast
Journal:  Cancers (Basel)       Date:  2018-11-12       Impact factor: 6.639

8.  Azasteroid Alkylators as Dual Inhibitors of AKT and ERK Signaling for the Treatment of Ovarian Carcinoma.

Authors:  Panagiotis Dalezis; Eleni Geromichalou; Aikaterini Polonifi; Sofia Sagredou; Nikolaos Nikoleousakos; Michael Nikolaou; Vasiliki Sarli; Mihalis I Panayiotidis; Dimitrios T Trafalis
Journal:  Cancers (Basel)       Date:  2020-05-16       Impact factor: 6.639

9.  Pure dysgerminoma of the ovary: CT and MRI features with pathological correlation in 13 tumors.

Authors:  Shuhui Zhao; Fan Sun; Lei Bao; Caiting Chu; Haiming Li; Qiufeng Yin; Wenbin Guan; Dengbin Wang
Journal:  J Ovarian Res       Date:  2020-06-17       Impact factor: 4.234

10.  Development and Validation of a Prognostic Prediction Model for Postoperative Ovarian Sex Cord-Stromal Tumor Patients.

Authors:  Danming You; Zuyu Zhang; Mingzhu Cao
Journal:  Med Sci Monit       Date:  2020-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.